Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis

Trima Pharmaceuticals

Status and phase: Withdrawn; Phase 4

Conditions: Diaper Rash

Treatments: Other: Desitin Creamy Ointment; Other: Moussik Diaper Rash Mousse

Study type: Interventional

Funder types: Industry

Identifiers

NCT01167465

Diaper Rash

Details and patient eligibility

About

The purpose of this clinical observation is to evaluate the safety and consumers' satisfaction of Moussik vs Desitin Creamy ointment as a diaper rash protection product.

Sex: All

Ages: 3 to 18 months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male or female infants aged between 3-18 months who are routine users of disposable diapers

Exclusion criteria

• Children with symptoms of systemic disease or skin lesions.
• Children diagnosed as having diaper dermatitis at baseline
• Known hypersensitivity to any of the components of the trial preparations.
• Children suffering from atopic diseases.
• Children who have participated during the last month in another clinical trial.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind